tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Technical Analysis

Compare
297 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is 0.49, suggesting TransCode Therapeutics is a Sell.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 6.09, while TransCode Therapeutics’s (RNAZ) share price is $6.16, making it a Buy.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 7.21, while TransCode Therapeutics’s (RNAZ) share price is $6.16, making it a Sell.

TransCode Therapeutics (RNAZ) Pivot Points

Feb 06, 2025, 11:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.11
5.81
6.66
7.36
8.21
8.91
9.76
Fibonacci
5.81
6.41
6.77
7.36
7.96
8.32
8.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Feb 06, 2025, 11:13 AM
Period
Simple
Exponential
MA5
7.53Sell
7.12Sell
MA10
7.05Sell
6.76Sell
MA20
5.21Buy
6.09Buy
MA50
6.47Sell
7.21Sell
MA100
11.41Sell
10.15Sell
MA200
18.08Sell
15.85Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 6.76, while TransCode Therapeutics’s (RNAZ) share price is $6.16, making it a Sell.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 10.15, while TransCode Therapeutics’s (RNAZ) share price is $6.16, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $6.16 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 6.47, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.16 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 11.41, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.16 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 18.08, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Feb 06, 2025, 11:13 AM
Name
Value
Implied Action
RSI (14)
50.38
Neutral
STOCH (9,6)
28.04
Neutral
STOCHRSI (14)
30.55
Neutral
MACD (12,26)
0.49
Sell
ADX (14)
53.51
Sell
Williams %R
-76.43
Buy
CCI (14)
30.21
Neutral
ATR (14)
2.04
-
Ultimate Oscillator
30.95
Neutral
ROC
83.33
Buy
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 50.38, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 53.51, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is 30.21, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is 83.33, creating a Buy signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Sell.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 50.38, which suggests RNAZ is a Neutral.
      What is RNAZ’s MACD?
      RNAZ’s MACD is 0.49, which suggests RNAZ is a Sell.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 7.53, which suggests RNAZ is a Sell.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 5.21, which suggests RNAZ is a Buy.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 6.47, which suggests RNAZ is a Sell.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 18.08, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -76.43, which suggests RNAZ is a Buy.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is 30.21, which suggests RNAZ is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis